NPPA computed the Retail Price of Atorvastatin calcium IP eq. to Atorvastatin 40 mg + Clopidogrel bisulphate IP e.q. to Clopidogrel 75 mg for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Torrent Pharmaceuticals Limited (Marketer)

Feb 21, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Compliance

The National Pharmaceutical Pricing Authority (NPPA) on February 19, 2025, issued the Computation of Retail Price of Atorvastatin calcium IP eq. to Atorvastatin 40 mg + Clopidogrel bisulphate IP e.q. to Clopidogrel 75 mg for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Torrent Pharmaceuticals Limited (Marketer)

The following has been stated namely: -

• The Retail Price has been computed based on the data from June, 2024

• The Retail Price has been computed for Each Film Coated Tablet Containing Atorvastatin calcium IP eq. to Atorvastatin 40 mg + Clopidogrel bisulphate IP e.q. to Clopidogrel 75 mg for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Torrent Pharmaceuticals Limited (Marketer)

• The Total MAT is 2,74,31,750

[Notification No. 19(4446)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT